To identify the drugs which could have a synergetic effect with ferroptosis-inducers, we screened 75 FDA-approved cancer drugs and found that fludarabine phosphate (F-ara-A) inhibited NFS1 and GSS expression most (Figure 8a). The gene discussed is NFS1; the disease is cancer.